Open AccessDiagnostic and prognostic impact of mucin 1–6 expression in non-small cell lung cancer
Author(s) -
William Sterlacci,
Michael Fiegl,
Lothar Veits,
Alexandar Tzankov
Publication year - 2018
Publication title -
indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_678_17
Subject(s) - medicine , muc1 , adenocarcinoma , lung cancer , oncology , immunohistochemistry , epidermal growth factor receptor , pathological , pathology , metastasis , mucin , survival analysis , cancer
The prognostic significance and clinico-pathological characterization of mucin (MUC) expression in non-small cell lung cancer (NSCLC) is controversial and little studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom